The article describes a successful experience of using high-dose rate brachytherapy (192Ir) in patients with local recurrence of hormone-resistant prostate cancer. High-dose rate brachytherapy allowed to achieve local biochemical control of prostate cancer without toxicity to pelvic organs, thus, maintaining the quality of life. © 2018 ABC-press Publishing House. All rights reserved
Purpose: To review and analyze the published data on high-dose-rate brachytherapy as monotherapy in ...
A 47-year-old Japanese man was diagnosed with prostate cancer in February 1995 (Initial PSA 77.2 ng/...
Purpose: Recent work has demonstrated the return of hormone sensitivity after palliative chemotherap...
The article describes a successful experience of using high-dose rate brachytherapy (192Ir) in patie...
Second salvage treatment for local recurrence of prostate cancer using high-dose-rate brachytherapy:...
A significant proportion of patients with prostate cancer experience biochemical failure following p...
Background. Prostate cancer (PCa) is one of the most common malignant diseases in men worldwide, wit...
Introduction Isolated local recurrence of prostate cancer following primary radiotherapy or brachyt...
PURPOSE: We report the toxicity and biochemical tumor control outcome of a prospective Phase II stud...
Copyright © 2015 Shogo Hosogoe et al.This is an open access article distributed under the Creative C...
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate...
International audienceSalvage brachytherapy after a first prostate radiation therapy is an emerging ...
AbstractPurposeWe report the toxicity and biochemical tumor control outcome of a prospective Phase I...
No standard treatment exists for locally relapsed prostate cancer after primary external beam radiot...
PurposeSalvage high-dose-rate brachytherapy (sHDRBT) for locally recurrent prostate cancer after def...
Purpose: To review and analyze the published data on high-dose-rate brachytherapy as monotherapy in ...
A 47-year-old Japanese man was diagnosed with prostate cancer in February 1995 (Initial PSA 77.2 ng/...
Purpose: Recent work has demonstrated the return of hormone sensitivity after palliative chemotherap...
The article describes a successful experience of using high-dose rate brachytherapy (192Ir) in patie...
Second salvage treatment for local recurrence of prostate cancer using high-dose-rate brachytherapy:...
A significant proportion of patients with prostate cancer experience biochemical failure following p...
Background. Prostate cancer (PCa) is one of the most common malignant diseases in men worldwide, wit...
Introduction Isolated local recurrence of prostate cancer following primary radiotherapy or brachyt...
PURPOSE: We report the toxicity and biochemical tumor control outcome of a prospective Phase II stud...
Copyright © 2015 Shogo Hosogoe et al.This is an open access article distributed under the Creative C...
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate...
International audienceSalvage brachytherapy after a first prostate radiation therapy is an emerging ...
AbstractPurposeWe report the toxicity and biochemical tumor control outcome of a prospective Phase I...
No standard treatment exists for locally relapsed prostate cancer after primary external beam radiot...
PurposeSalvage high-dose-rate brachytherapy (sHDRBT) for locally recurrent prostate cancer after def...
Purpose: To review and analyze the published data on high-dose-rate brachytherapy as monotherapy in ...
A 47-year-old Japanese man was diagnosed with prostate cancer in February 1995 (Initial PSA 77.2 ng/...
Purpose: Recent work has demonstrated the return of hormone sensitivity after palliative chemotherap...